Characteristics of peripheral neuropathy and its impact on quality of life, physical function in non-metastasis breast cancer patients.

This cross sectional observational study aims to evaluate the characteristics of chemotherapy induced peripheral neuropathy and its impact on quality of life and physical function in non metastatic breast cancer patients who have completed more than three cycles of chemotherapy (adriamycin, docetaxel, cyclophosphamide or combinations) regardless of surgery or radiotherapy status. Neuropathy symptoms will be assessed using the EORTC QLQ-CIPN20 questionnaire and the Revised Total Neuropathy Score (RTNS). Vibration perception threshold assessed  using a biothesiometer. Physical function and fall risk will be measured by the Timed Up Go (TUG) test.These will be evaluated a single time when the participant joins the study. Data on chemotherapy details, surgery, and radiotherapy status will be documented. All assessments will be performed at baseline during study enrolment. Ethical approval has been obtained, and informed consent will be taken from all participants.